Achillion Pharmaceuticals Inc

ACHN 
(NASDAQ) 
 
$ 3.640 <%= Resources.Global.txtDown %>
Updated 24/05/2018
Change % -1.09% Stock price decreasing
Change -0.04 Stock price decreasing
Volume 80,087
High $ 3.685
Low $ 3.615
Open $ 3.660
ISIN
Prev close $ 3.680
# of shares 138.34M
Market cap 503.56M USD
Intraday

Market closed
Achillion Pharmaceuticals Inc
Market is closed, opens at 14:30
 
Price development Latest 1 week 1 month 3 months 6 months 1 year
 
  3.64 -1.6% Stock price decreasing -1.1% Stock price decreasing 23.2% Stock price increasing 12.3% Stock price increasing -12.3% Stock price decreasing
Powered by TradingView

News about Achillion Pharmaceuticals Inc

  • English
  • Regulatory news

Company profile

Achillion Pharmaceuticals Inc is a biotechnology company that seeks to discover and commercialize treatments for rare diseases. The company is engaged solely in the discovery and development of innovative small-molecule drug therapies for infectious diseases and immune system disorders. Achillion specializes in structural biology, medicinal chemistry, and antimicrobial discovery research. The company generates revenue from product sales, regulatory and commercialization milestones, and royalties. Achillion also uses collaborative and licensing agreements.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
 
25 May 2018 00:29:03
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180524.2 - EUROWEB3 - 2018-05-25 01:29:03 - 2018-05-25 00:29:03 - 1000 - Website: OKAY